ArticleInvestigational new drugs2020

Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).

Ruud van der Noll et al.PubMed ↗Publisher ↗

No numbers read from the abstract.